This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Dr Reddy Laboratories Ltd (RDY)

NYSE: Health Care

Company Cash Flow
Mar 2015 Mar 2014 Mar 2013 Mar 2012
Cash Flow From Operating Activities
Net Income (Loss) 354.64M 359.47M 308.34M 0.00
Operating Gains/Losses -12.89M -7.42M -8.45M -4.05M
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -174.37M 1.97M -116.53M -136.02M
(Increase) Decrease in Inventories -87.10M -66.36M -71.13M -85.50M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables 879.45K -35.59M 33.91M 18.64M
(Decrease) Increase In Other Current Liabilities 0.00 0.00 -101.77M -89.41M
(Increase) Decrease In Other Working Capital 20.10M -73.62M -87.87M 26.74M
Other Non-Cash Items 73.81M 28.04M 96.22M 401.96M
Net Cash From Continuing Operations 400.28M 325.23M 244.77M 317.49M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 400.28M 325.23M 244.77M 317.49M
Sale of Property, Plant & Equipment 2.75M 1.90M 5.84M 806.01K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -245.08M -177.58M -122.59M -166.35M
Acquisitions -4.41M 0.00 -32.09M 0.00
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 13.06M 16.43M 3.35M 6.53M
Cash Provided by Financing Activities
Net Cash From Investing Activities -366.23M -277.72M -256.29M -366.93M
Issuance of Debt 0.00 168.77M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 79.95K 33.42K 18.38K 117.95K
Repayment of Long-Term Debt -59.42M -3.46M 0.00 0.00
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends -57.36M -49.88M -49.88M -43.56M
Other Financing Charges, Net 50.85M -119.09M 16.93M 116.87M
Net Cash From Financing Activities -65.85M -3.63M -32.94M 73.43M
Effect of Exchange Rate Changes -17.08M 12.88M 1.73M 9.81M
Net Change in Cash & Cash Equivalents -48.88M 56.76M -42.73M 33.79M
RDY News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

RDY Dr Reddy Laboratories Ltd

Chart of RDY

Analysts Ratings for RDY

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0

RDY Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs